title: Telomere dysfunction promotes metastasis in a TERC null mouse model of head and neck cancer.
abstract: Squamous cell carcinoma arises from highly proliferative basal layer epithelial cells, which normally divide for a short time before detaching from the basement membrane and undergoing terminal differentiation. Basal layer cells in stratified epithelia express the reverse transcriptase known as telomerase. Most human cells do not express telomerase and therefore are subject to loss of telomeric DNA with age due to the inability of lagging strand synthesis to completely replicate chromosomal ends. Late generation telomerase deficient mice exhibit signs of premature aging including reduced function of proliferating cellular compartments. We examined development of squamous cell carcinoma in a telomerase deficient murine background with long and short telomeres. G1 Terc-/- mice (long telomeres) had fewer lymph node metastases, which correlated with increased numbers of apoptotic cells in these tumors compared with wild-type mice. However, G5 Terc-/- mice with short telomeres had increased metastatic tumor burden similar to wild type mice. This increased metastasis correlated with genomic instability and aneuploidy in tumor cells from G5 Terc-/- mice. A number of similarities with human SCC were noted in the mouse model, and dramatic differences in global gene expression profiles were shown between primary and metastatic tumors. We concluded that telomere shortening promotes metastatic tumor development in a Terc null mouse model of head and neck cancer.
authors: University of Illinois Cancer Center, University of Illinois at Chicago, Chicago, IL 60612, USA.
authors: Bojana
authors: B
authors: Bojovic
authors: David L
authors: DL
authors: Crowe
references: EMBO J. 2005 Mar 23;24(6):1095-103
references: 15775986
references: Cancer. 1994 Jul 15;74(2):565-72
references: 8033034
references: Mol Cancer Res. 2007 Apr;5(4):351-62
references: 17426250
references: Science. 2002 Jul 26;297(5581):565-9
references: 12142527
references: Int J Oncol. 2008 Feb;32(2):491-8
references: 18202773
references: Head Neck. 2002 Dec;24(12):1060-7
references: 12454944
references: J Biol Chem. 2007 Sep 7;282(36):26381-91
references: 17616526
references: Cell. 1999 Mar 5;96(5):701-12
references: 10089885
references: Oral Dis. 2000 Mar;6(2):65-74
references: 10702782
references: Comp Med. 2006 Feb;56(1):17-22
references: 16521855
references: Nat Genet. 2007 Nov;39(11):1376-83
references: 17906625
references: Nature. 2007 Aug 16;448(7155):767-74
references: 17700693
references: Int J Oncol. 2005 Dec;27(6):1583-96
references: 16273215
references: Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6476-81
references: 8692840
references: Curr Opin Genet Dev. 2001 Aug;11(4):410-7
references: 11448627
references: Science. 1994 Dec 23;266(5193):2011-5
references: 7605428
references: Int Immunopharmacol. 2008 Feb;8(2):300-6
references: 18182244
references: Cancer Res. 2004 Sep 1;64(17):6166-73
references: 15342401
references: J Natl Cancer Inst. 2003 Aug 20;95(16):1211-8
references: 12928346
references: J Invest Dermatol. 2002 Nov;119(5):1014-9
references: 12445186
references: J Exp Clin Cancer Res. 2005 Dec;24(4):639-46
references: 16471328
references: Head Neck. 2006 Apr;28(4):330-8
references: 16470878
references: Science. 1998 Jan 16;279(5349):349-52
references: 9454332
references: Biochim Biophys Acta. 2001 Mar 19;1518(1-2):1-6
references: 11267653
references: Nature. 2000 Aug 10;406(6796):641-5
references: 10949306
references: Int J Oncol. 1999 Sep;15(3):519-23
references: 10427134
references: Am J Clin Dermatol. 2008;9(1):15-31
references: 18092840
references: Biochem Biophys Res Commun. 2004 Mar 12;315(3):686-91
references: 14975755
references: Mutat Res. 1991 Jan;256(1):45-8
references: 1944386
references: Oral Oncol. 2007 Feb;43(2):122-9
references: 16798059
references: Jpn J Cancer Res. 1997 Aug;88(8):732-7
references: 9330604
references: Int J Oncol. 2003 Jun;22(6):1285-90
references: 12738995
references: Nat Genet. 2000 Sep;26(1):114-7
references: 10973262
references: J Oral Pathol Med. 2004 Oct;33(9):538-42
references: 15357674
references: Oncogene. 2002 Apr 25;21(18):2846-53
references: 11973644
references: Cancer Res. 1995 Oct 15;55(20):4566-9
references: 7553630
references: Biochim Biophys Acta. 1999 May 14;1445(2):207-15
references: 10320773
references: Dis Markers. 2008;24(1):41-50
references: 18057535
references: Int J Oncol. 2005 Sep;27(3):847-54
references: 16077937
references: Mol Cell Biol. 2005 May;25(10):3982-96
references: 15870272
references: EMBO Rep. 2005 Mar;6(3):268-74
references: 15731767
references: Cell. 2000 Aug 18;102(4):451-61
references: 10966107
references: J Cancer Res Clin Oncol. 2004 Jul;130(7):411-6
references: 15160288
references: Nucleic Acids Res. 2001 Jul 1;29(13):2789-94
references: 11433024
references: Nature. 2000 Nov 2;408(6808):53-6
references: 11081503
references: Nature. 1998 Apr 9;392(6676):569-74
references: 9560153